company background image
SPEC logo

INSPECS Group AIM:SPEC Stock Report

Last Price

UK£0.40

Market Cap

UK£40.2m

7D

-6.0%

1Y

-19.4%

Updated

13 Apr, 2025

Data

Company Financials +

INSPECS Group plc

AIM:SPEC Stock Report

Market Cap: UK£40.2m

SPEC Stock Overview

Designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products worldwide. More details

SPEC fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 58.5% below our estimate of its fair value

Earnings are forecast to grow 97.09% per year

Trading at good value compared to peers and industry

Risk Analysis

Does not have a meaningful market cap (£40M)

Volatile share price over the past 3 months compared to the UK market


INSPECS Group plc Competitors

Abingdon Health

AIM:ABDX

UK£23.5m

Tristel

AIM:TSTL

UK£150.3m

MyHealthChecked

AIM:MHC

UK£7.3m

Cambridge Nutritional Sciences

AIM:CNSL

UK£6.4m

Price History & Performance

Summary of share price highs, lows and changes for INSPECS Group
Historical stock prices
Current Share PriceUK£0.40
52 Week HighUK£0.78
52 Week LowUK£0.37
Beta2.2
1 Month Change-21.00%
3 Month Change-4.82%
1 Year Change-19.39%
3 Year Change-89.18%
5 Year Change-75.69%
Change since IPO-79.74%

Recent News & Updates

Recent updates

INSPECS Group plc (LON:SPEC) Shares Fly 26% But Investors Aren't Buying For Growth

Feb 11
INSPECS Group plc (LON:SPEC) Shares Fly 26% But Investors Aren't Buying For Growth

Lacklustre Performance Is Driving INSPECS Group plc's (LON:SPEC) 29% Price Drop

Dec 10
Lacklustre Performance Is Driving INSPECS Group plc's (LON:SPEC) 29% Price Drop

INSPECS Group plc's (LON:SPEC) Revenues Are Not Doing Enough For Some Investors

Sep 17
INSPECS Group plc's (LON:SPEC) Revenues Are Not Doing Enough For Some Investors

Is INSPECS Group (LON:SPEC) A Risky Investment?

Jun 09
Is INSPECS Group (LON:SPEC) A Risky Investment?

INSPECS Group plc (LON:SPEC) Surges 27% Yet Its Low P/S Is No Reason For Excitement

May 04
INSPECS Group plc (LON:SPEC) Surges 27% Yet Its Low P/S Is No Reason For Excitement

INSPECS Group plc's (LON:SPEC) Shares Lagging The Industry But So Is The Business

Jan 18
INSPECS Group plc's (LON:SPEC) Shares Lagging The Industry But So Is The Business

A Look At The Intrinsic Value Of INSPECS Group plc (LON:SPEC)

Oct 30
A Look At The Intrinsic Value Of INSPECS Group plc (LON:SPEC)

A Look At The Intrinsic Value Of INSPECS Group plc (LON:SPEC)

May 23
A Look At The Intrinsic Value Of INSPECS Group plc (LON:SPEC)

Returns On Capital At INSPECS Group (LON:SPEC) Paint A Concerning Picture

Mar 04
Returns On Capital At INSPECS Group (LON:SPEC) Paint A Concerning Picture

A Look At The Fair Value Of INSPECS Group plc (LON:SPEC)

Feb 01
A Look At The Fair Value Of INSPECS Group plc (LON:SPEC)

INSPECS Group (LON:SPEC) Has A Pretty Healthy Balance Sheet

Dec 06
INSPECS Group (LON:SPEC) Has A Pretty Healthy Balance Sheet

INSPECS Group (LON:SPEC) Might Be Having Difficulty Using Its Capital Effectively

Nov 01
INSPECS Group (LON:SPEC) Might Be Having Difficulty Using Its Capital Effectively

Estimating The Intrinsic Value Of INSPECS Group plc (LON:SPEC)

Aug 13
Estimating The Intrinsic Value Of INSPECS Group plc (LON:SPEC)

Is It Time To Consider Buying Inspecs Group plc (LON:SPEC)?

Jun 23
Is It Time To Consider Buying Inspecs Group plc (LON:SPEC)?

Calculating The Fair Value Of Inspecs Group plc (LON:SPEC)

May 10
Calculating The Fair Value Of Inspecs Group plc (LON:SPEC)

The Inspecs Group (LON:SPEC) Share Price Is Up 92% And Shareholders Are Holding On

Mar 16
The Inspecs Group (LON:SPEC) Share Price Is Up 92% And Shareholders Are Holding On

What Type Of Shareholders Own The Most Number of Inspecs Group plc (LON:SPEC) Shares?

Feb 09
What Type Of Shareholders Own The Most Number of Inspecs Group plc (LON:SPEC) Shares?

A Look At The Fair Value Of Inspecs Group plc (LON:SPEC)

Dec 17
A Look At The Fair Value Of Inspecs Group plc (LON:SPEC)

Shareholder Returns

SPECGB Medical EquipmentGB Market
7D-6.0%-4.3%-1.0%
1Y-19.4%-6.2%-3.0%

Return vs Industry: SPEC underperformed the UK Medical Equipment industry which returned -6.2% over the past year.

Return vs Market: SPEC underperformed the UK Market which returned -3% over the past year.

Price Volatility

Is SPEC's price volatile compared to industry and market?
SPEC volatility
SPEC Average Weekly Movement8.5%
Medical Equipment Industry Average Movement6.9%
Market Average Movement5.5%
10% most volatile stocks in GB Market10.3%
10% least volatile stocks in GB Market3.1%

Stable Share Price: SPEC's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: SPEC's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks.

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

About the Company

FoundedEmployeesCEOWebsite
19881,673Richard Peckwww.inspecs.com

INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products worldwide. The company offers its products under the JOSEPH, CAT, Viktor & Rolf, Hype, Henri Lloyd, Barbour, Liberty, O’Neill, Lyle & Scott, SUPERDRY, RADLEY LONDON, Temperly London, TED BAKER LONDON, MINI, L.A.M.B., Barbour International, Marc O’Polo, TALBOT RUNHOF Eyewear, BUFFALO David Bitton, Free Country, BOTANIQ, SAVILE ROW Titanium, SAVILE ROW, BRENDEL Eyewear, FREIGEIST, HUMPHREY’S eyewear, JOS ESCHENBACH, and TITANFLEX brands through optical and retail outlets. INSPECS Group plc was founded in 1988 and is based in Bath, the United Kingdom.

INSPECS Group plc Fundamentals Summary

How do INSPECS Group's earnings and revenue compare to its market cap?
SPEC fundamental statistics
Market capUK£40.16m
Earnings (TTM)-UK£4.61m
Revenue (TTM)UK£198.26m

0.2x

P/S Ratio

-8.7x

P/E Ratio

Is SPEC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SPEC income statement (TTM)
RevenueUK£198.26m
Cost of RevenueUK£94.81m
Gross ProfitUK£103.45m
Other ExpensesUK£108.06m
Earnings-UK£4.61m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.045
Gross Margin52.18%
Net Profit Margin-2.32%
Debt/Equity Ratio47.5%

How did SPEC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/13 16:25
End of Day Share Price 2025/04/11 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

INSPECS Group plc is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Charles HallPeel Hunt LLP